Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Anderson

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)Kathleen N Moore, Michael Bookman, Jalid Sehouli, et al.
JAMA Internal Medicine|January 31, 2017
Implementation of Lung Cancer Screening in the Veterans Health AdministrationLinda S Kinsinger, Charles Anderson, Jane Kim, et al.
The Lancet. Infectious Diseases|August 1, 2018
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adultsIssaka Sagara, Sara A Healy, Mahamadoun H Assadou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)Bradley J Monk, Christine Parkinson, Myong Cheol Lim, et al.
Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.
Nature|July 1, 2021
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunityAgnes Mwakingwe-Omari, Sara A Healy, Jacquelyn Lane, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)Kathleen N Moore, Michael Bookman, Jalid Sehouli, et al.
JAMA Internal Medicine|January 31, 2017
Implementation of Lung Cancer Screening in the Veterans Health AdministrationLinda S Kinsinger, Charles Anderson, Jane Kim, et al.
The Lancet. Infectious Diseases|August 1, 2018
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adultsIssaka Sagara, Sara A Healy, Mahamadoun H Assadou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)Bradley J Monk, Christine Parkinson, Myong Cheol Lim, et al.
Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.
Nature|July 1, 2021
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunityAgnes Mwakingwe-Omari, Sara A Healy, Jacquelyn Lane, et al.
Pageof 7